CD274 and neoplasm: PD-L1 expressed in cancer cells could specifically bind to the receptor (PD-1) on the surface of activated T cells in the tumor microenvironment and transmit negative regulatory signals to inhibit T cell activation, proliferation, or cytokine secretion (117–119).